VERAVera Therapeutics, Inc.

VERA Stock Price, Valuation & Chart | Vera Therapeutics, Inc.

Compare

$35.660+1.43 (+4.18%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology VERA intrinsic value VERA calculated fair value vs price

Overview Financials Dividends Ratios

VERA Historical price chart

VERA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.56B

PE Ratio-6.09

EPS-5.86

Trading Volume1.76M

Today's High/Low35.71/33.81

Dividend Yield0.00

52 Week High/Low56.05/21.71

Shares Outstanding71.78M

VERA Financial Statement

VERA Analyst ratings

VERA Analysis & performance metrics

VERA Company profile

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the…

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also…

VERA Management team

Name

Position

Debra Charlesworth

Vice President of Corporate Communications

David L. Johnson M.B.A.

Chief Opearating Officer

Marshall W. Fordyce M.D.CEO

Founder, President, Chief Executive Officer & Director

Jason S. Carter

Chief Legal Officer

Emma Haywood

Vice President of Marketing

Joseph R. Young M.B.A.

Senior Vice President of Finance & Chief Accounting Officer

Allen Ebens B.Sc., Ph.D.

Executive Vice President of Research

Kelly Rauber

Senior Vice President of Human Resources

Name

Position

Debra Charlesworth

Vice President of Corporate Communications

David L. Johnson M.B.A.

Chief Opearating Officer

Marshall W. Fordyce M.D.CEO

Founder, President, Chief Executive Officer & Director

Jason S. Carter

Chief Legal Officer

Emma Haywood

Vice President of Marketing

Joseph R. Young M.B.A.

Senior Vice President of Finance & Chief Accounting Officer

Allen Ebens B.Sc., Ph.D.

Executive Vice President of Research

Kelly Rauber

Senior Vice President of Human Resources

Management Team

Debra Charlesworth

Vice President of Corporate Communications

David L. Johnson M.B.A.

Chief Opearating Officer

Marshall W. Fordyce M.D.CEO

Founder, President, Chief Executive Officer & Director

Jason S. Carter

Chief Legal Officer

Emma Haywood

Vice President of Marketing

Joseph R. Young M.B.A.

Senior Vice President of Finance & Chief Accounting Officer

Allen Ebens B.Sc., Ph.D.

Executive Vice President of Research

Kelly Rauber

Senior Vice President of Human Resources

Management

Debra Charlesworth

Vice President of Corporate Communications

David L. Johnson M.B.A.

Chief Opearating Officer

Marshall W. Fordyce M.D.CEO

Founder, President, Chief Executive Officer & Director

Jason S. Carter

Chief Legal Officer

Emma Haywood

Vice President of Marketing

Joseph R. Young M.B.A.

Senior Vice President of Finance & Chief Accounting Officer

Allen Ebens B.Sc., Ph.D.

Executive Vice President of Research

Kelly Rauber

Senior Vice President of Human Resources

Total 8 executives

VERA Frequently asked questions

What is Vera Therapeutics, Inc. (VERA) Stock Price?

Current stock price of Vera Therapeutics, Inc. (VERA) stock is $35.660. The stock price is +4.18% higher in the session. The intraday range can be seen from this page. Volume of Vera Therapeutics, Inc. (VERA) stock is 1.76M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Vera Therapeutics, Inc. (VERA) stock price going up or down today?

The stock price of Vera Therapeutics, Inc. (VERA) can change with earnings, company news, and overall market sentiment. Vera Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Vera Therapeutics, Inc. stock expensive at its current price?

Whether Vera Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VERA on this page is -6.09. EPS on this page is -5.86. Compare those figures with peers and growth expectations before deciding if the current Vera Therapeutics, Inc. price is justified.

How has the stock price of Vera Therapeutics, Inc. (VERA) performed historically?

Historical performance for Vera Therapeutics, Inc. (VERA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VERA reacted to past earnings and market events.

Should I buy Vera Therapeutics, Inc. (VERA) stock, at this price?

Buying Vera Therapeutics, Inc. (VERA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.